These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Overview of the clinical pharmacology of antiarrhythmic drugs. Woosley RL; Funck-Brentano C Am J Cardiol; 1988 Jan; 61(2):61A-69A. PubMed ID: 2447771 [TBL] [Abstract][Full Text] [Related]
3. From first class to third class: recent upheaval in antiarrhythmic therapy--lessons from clinical trials. Lazzara R Am J Cardiol; 1996 Aug; 78(4A):28-33. PubMed ID: 8780326 [TBL] [Abstract][Full Text] [Related]
4. The clinical use of class IC antiarrhythmic drugs. Abi Samra F J La State Med Soc; 1989 May; 141(5):27-31. PubMed ID: 2499646 [TBL] [Abstract][Full Text] [Related]
7. New drugs in the management of ventricular arrhythmias. Sanna GP G Ital Cardiol; 1984 Oct; 14(10):788-97. PubMed ID: 6083894 [TBL] [Abstract][Full Text] [Related]
8. Clinical pharmacokinetics of the newer antiarrhythmic agents. Gillis AM; Kates RE Clin Pharmacokinet; 1984; 9(5):375-403. PubMed ID: 6437721 [TBL] [Abstract][Full Text] [Related]
9. [New aspects of the electrophysiologic effect of antiarrhythmic agents]. Antoni H; Weirich J Herz; 1990 Apr; 15(2):61-9. PubMed ID: 2188893 [TBL] [Abstract][Full Text] [Related]
10. Investigational antiarrhythmic drugs for the treatment of ventricular rhythm disturbances. Pratt CM; Luck JC; Mann DE; Wyndham CR Cardiol Clin; 1984 Feb; 2(1):35-46. PubMed ID: 6443563 [TBL] [Abstract][Full Text] [Related]
11. A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators. Mason JW N Engl J Med; 1993 Aug; 329(7):452-8. PubMed ID: 8332150 [TBL] [Abstract][Full Text] [Related]
13. Can antiarrhythmic drugs survive survival trials? Pratt CM; Waldo AL; Camm AJ Am J Cardiol; 1998 Mar; 81(6A):24D-34D. PubMed ID: 9537220 [TBL] [Abstract][Full Text] [Related]
14. Circadian pattern of arrhythmic death in patients receiving encainide, flecainide or moricizine in the Cardiac Arrhythmia Suppression Trial (CAST). Peters RW; Mitchell LB; Brooks MM; Echt DS; Barker AH; Capone R; Liebson PR; Greene HL J Am Coll Cardiol; 1994 Feb; 23(2):283-9. PubMed ID: 8294678 [TBL] [Abstract][Full Text] [Related]
15. [What is the latest in anti-arrhythmia therapy?]. Gloor HO Schweiz Med Wochenschr; 1991 Nov; 121(47):1711-4. PubMed ID: 1720259 [TBL] [Abstract][Full Text] [Related]
16. Implications of the Cardiac Arrhythmia Suppression Trial for antiarrhythmic drug treatment. Bigger JT Am J Cardiol; 1990 Feb; 65(8):3D-10D; discussion 68D-71D. PubMed ID: 2106253 [TBL] [Abstract][Full Text] [Related]
17. Clinical pharmacology of antiarrhythmic agents. Kelliher GJ; Kowey P; Engel T; Wetstein L Cardiovasc Clin; 1985; 16(1):287-305. PubMed ID: 2874883 [No Abstract] [Full Text] [Related]
19. Blockade of 2,4-dinitrophenol induced ATP sensitive potassium current in guinea pig ventricular myocytes by class I antiarrhythmic drugs. Wu B; Sato T; Kiyosue T; Arita M Cardiovasc Res; 1992 Nov; 26(11):1095-101. PubMed ID: 1291087 [TBL] [Abstract][Full Text] [Related]